Какова цена за LifeMD, Inc. (LFMDP)

Цена за LifeMD, Inc. (LFMDP) Это $23.31

Какова рыночная капитализация для LifeMD, Inc. (LFMDP)

Рыночная капитализация для LifeMD, Inc. (LFMDP) Это $1.05B

Доходы LifeMD, Inc. (LFMDP)

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.

Год	Выручка	Изменить
2026 (TTM)	$234.96M	10.59%
2024	$212.45M	39.27%
2023	$152.55M	28.15%
2022	$119.03M	28.16%
2021	$92.88M	149.04%
2020	$37.29M	199.10%
2019	$12.47M	49.79%
2018	$8.32M	64.68%
2017	$5.05M	-3.51%
2016	$5.24M	329.79%
2015	$1.22M	70.67%
2014	$714.16K	-11.65%
2013	$808.36K	19.97%
2012	$673.78K	-9.42%
2011	$743.83K	0.00%

Год

Выручка

Изменить

2026 (TTM)

$234.96M

10.59%

2024

$212.45M

39.27%

2023

$152.55M

28.15%

2022

$119.03M

28.16%

2021

$92.88M

149.04%

2020

$37.29M

199.10%

2019

$12.47M

49.79%

2018

$8.32M

64.68%

2017

$5.05M

-3.51%

2016

$5.24M

329.79%

2015

$1.22M

70.67%

2014

$714.16K

-11.65%

2013

$808.36K

19.97%

2012

$673.78K

-9.42%

2011

$743.83K

0.00%

Компания	Выручка	Разница в выручке	Страна
Alibaba Health Information Technology Limited 0241.HK	$5.63B	2,294.25%	HK
Raia Drogasil S.A. RADL3.SA	$8.02B	3,314.64%	BR
MatsukiyoCocokara & Co. 3088.T	$7.01B	2,882.83%	JP
Yifeng Pharmacy Chain Co., Ltd. 603939.SS	$3.39B	1,342.46%	CN
Sugi Holdings Co.,Ltd. 7649.T	$6.36B	2,608.75%	JP

Компания

Выручка

Разница в выручке

Страна